Aminolevulinic acid and Olmesartan Medoxomil and Hydrochlorothiazide
Determining the interaction of Aminolevulinic acid and Olmesartan Medoxomil and Hydrochlorothiazide and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.GENERALLY AVOID: Patients exposed to photosensitizing agents may be at increased risk of a phototoxic skin reaction (severe sunburn) during use of aminolevulinic acid. MANAGEMENT: Photosensitizing agents (e.g., fluoroquinolones, phenothiazines, retinoids, sulfonamides, sulfonylureas, tetracyclines, thiazide diuretics, griseofulvin, St. John's wort) and topical preparations containing aminolevulinic acid should generally not be administered for 24 hours before and after oral administration of aminolevulinic acid. Some authorities recommend avoiding exposure to any photosensitizing agent for up to 2 weeks after oral administration of aminolevulinic acid, if possible. Patients should also avoid exposure of the eyes and skin to sunlight or bright indoor lights (e.g., examination lamps, operating room lamps, tanning beds, lights at close proximity) for 48 hours after receiving aminolevulinic acid. References "Product Information. Gleolan (aminolevulinic acid)." NX Development Corp, Lexington, KY.
Professional:GENERALLY AVOID: Patients exposed to photosensitizing agents may be at increased risk of a phototoxic skin reaction (severe sunburn) during use of aminolevulinic acid.
MANAGEMENT: Photosensitizing agents (e.g., fluoroquinolones, phenothiazines, retinoids, sulfonamides, sulfonylureas, tetracyclines, thiazide diuretics, griseofulvin, St. John's wort) and topical preparations containing aminolevulinic acid should generally not be administered for 24 hours before and after oral administration of aminolevulinic acid. Some authorities recommend avoiding exposure to any photosensitizing agent for up to 2 weeks after oral administration of aminolevulinic acid, if possible. Patients should also avoid exposure of the eyes and skin to sunlight or bright indoor lights (e.g., examination lamps, operating room lamps, tanning beds, lights at close proximity) for 48 hours after receiving aminolevulinic acid.
- "Product Information. Gleolan (aminolevulinic acid)." NX Development Corp, Lexington, KY.
Generic Name: aminolevulinic acid
Brand name: Gleolan
Synonyms: n.a.
Generic Name: hydrochlorothiazide / olmesartan
Brand name: Benicar HCT
Synonyms: Hydrochlorothiazide and olmesartan, Olmesartan and Hydrochlorothiazide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aminolevulinic acid-Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide
- Aminolevulinic acid-Olmesartan, Amlodipine, and Hydrochlorothiazide
- Aminolevulinic acid-Olodaterol
- Aminolevulinic acid-Olodaterol and tiotropium
- Aminolevulinic acid-Olodaterol Hydrochloride
- Aminolevulinic acid-Olodaterol inhalation
- Olmesartan Medoxomil and Hydrochlorothiazide-Aminolevulinic Acid (Systemic)
- Olmesartan Medoxomil and Hydrochlorothiazide-Aminolevulinic Acid Gel
- Olmesartan Medoxomil and Hydrochlorothiazide-Aminolevulinic Acid Hydrochloride
- Olmesartan Medoxomil and Hydrochlorothiazide-Aminolevulinic Acid Solution
- Olmesartan Medoxomil and Hydrochlorothiazide-Aminolevulinic acid topical
- Olmesartan Medoxomil and Hydrochlorothiazide-Aminomine